As heart failure with preserved ejection fraction (HFpEF) rises to epidemic proportions, major steps in patient management and therapeutic development are badly needed. With the current position paper we seek to update our view on HFpEF as a highly complex systemic syndrome, from risk factors and mechanisms to long-term clinical manifestations. We will revise recent advances in animal model development, experimental set-ups and basic and translational science approaches to HFpEF research, highlighting their drawbacks and advantages. Directions are provided for proper model selection as well as for integrative functional evaluation from the in vivo setting to in vitro cell function testing. Additionally, we address new research challenges th...
There is an unmet need for effective treatment strategies to reduce morbidity and mortality in patie...
There is a lack of consensus on how we define heart failure with preserved ejection fraction (HFpEF)...
Heart failure is a complex and chronic condition with varying causes. Until about 10 years ago, hear...
As heart failure with preserved ejection fraction (HFpEF) rises to epidemic proportions, major steps...
As heart failure with preserved ejection fraction (HFpEF) rises to epidemic proportions, major steps...
Background: Information on the pathophysiological differences between heart failure with reduced eje...
Background: Information on the pathophysiological differences between heart failure with reduced e...
At this moment, more than 230,000 people in the Netherlands suffer from heart failure. More than hal...
There is an unmet need for effective treatment strategies to reduce morbidity and mortality in patie...
There is a lack of consensus on how we define heart failure with preserved ejection fraction (HFpEF)...
Heart failure is a complex and chronic condition with varying causes. Until about 10 years ago, hear...
As heart failure with preserved ejection fraction (HFpEF) rises to epidemic proportions, major steps...
As heart failure with preserved ejection fraction (HFpEF) rises to epidemic proportions, major steps...
Background: Information on the pathophysiological differences between heart failure with reduced eje...
Background: Information on the pathophysiological differences between heart failure with reduced e...
At this moment, more than 230,000 people in the Netherlands suffer from heart failure. More than hal...
There is an unmet need for effective treatment strategies to reduce morbidity and mortality in patie...
There is a lack of consensus on how we define heart failure with preserved ejection fraction (HFpEF)...
Heart failure is a complex and chronic condition with varying causes. Until about 10 years ago, hear...